News > Overview
We invite you to look through our recent company press releases, and read articles about us that have been in the press and other media outlets. For any specific enquiries, please email us at .(JavaScript must be enabled to view this email address)
Latest Press Releases
| Date | Title | Download |
| 20 Feb 2013 | Promising pre-clinical data in CF for ProtAffin AG’s PA401 to be presented at ATS meeting May 2013 |  |
| 20 Sep 2012 | ProtAffin wins prestigious EuropaBio Award for innovation | |
ProtAffin in the News
| Date | Title | |
| 24 Sep 2012 | ProtAffin wins EuropaBio Award for Most Innovative EU Biotech SME 2012 |
Website |
| 23 Aug 2012 | ProtAffin shortlisted for EuropaBio’s Most Innovative EU Biotech SME Award 2012 |
Website |
All Press Releases
| Date | Title | Download |
| 20 Feb 2013 | Promising pre-clinical data in CF for ProtAffin AG’s PA401 to be presented at ATS meeting May 2013 | |
| 20 Sep 2012 | ProtAffin wins prestigious EuropaBio Award for innovation | |
| 27 Jun 2012 | ProtAffin AG starts Phase 1 study for lead product PA401 in inflammatory lung disease |  |
| 22 May 2012 | ProtAffin AG releases new preclinical data for lead product PA401 in inflammatory lung disease | |
| 14 Dec 2011 | ProtAffin AG receives key grant for preclinical and clinical development | |
| 20 Oct 2011 | ProtAffin AG announces preclinical data in Multiple Sclerosis for MCP-1 decoy program | |
| 26 Sep 2011 | ProtAffin AG appoints Dr Mike Bartley as Chief Development Officer | |
| 25 Jul 2011 | ProtAffin AG strengthens Supervisory Board | |
| 14 Mar 2011 | ProtAffin AG granted patent in EU for CellJammer® discovery technology | |
| 15 Nov 2010 | ProtAffin AG receives grant from FFG for preclinical development of PA401in COPD | |
| 21 Sep 2010 | ProtAffin AG announces preclinical data in COPD for lead product PA401 | |
| 27 Jul 2010 | ProtAffin AG signs manufacturing contract for PA401 with CMC Biologics A/S | |
| 11 Sep 2009 | ProtAffin AG granted patent in USA for lead anti-inflammatory product PA401 | |
| 27 Apr 2009 | ProtAffin AG completes €14 million Series B financing | |
| 23 Jan 2009 | ProtAffin AG granted patent in EU for lead anti-inflammatory product PA401 | |
| 05 Sep 2008 | ProtAffin AG granted Orphan Drug Designation in the US for lead anti-inflammatory product | |
| 18 Jul 2008 | ProtAffin AG granted Orphan Medicinal Product Designation by EMEA for lead anti-inflammatory product | |
| 02 Apr 2008 | ProtAffin AG receives research grant | |
| 14 Jan 2008 | ProtAffin AG completes second closing of Series A financing | |
| 04 May 2007 | ProtAffin AG secures Series A financing | |
Events
|
ProtAffin is attending or presenting at the upcoming conferences:
|
||||||||||||||
ProtAffin in the News
| Date | Title | |
| 24 Sep 2012 | ProtAffin wins EuropaBio Award for Most Innovative EU Biotech SME 2012 |
Website |
| 23 Aug 2012 | ProtAffin shortlisted for EuropaBio’s Most Innovative EU Biotech SME Award 2012 |
Website |
| 21 May 2012 | CEO Jason Slingsby interview with PharmaTV at BioEurope |
Download |
| 16 Apr 2012 | ProtAffin’s glycan-binding decoy protein technology reviewed in sp2 article |
Download |
| 31 Mar 2012 | CEO Jason Slingsby interviewed on Stock News Now (SNN) at the Biotech Showcase 2012 event |
Website |
| 16 Feb 2012 | CEO Jason Slingsby speaks at a recent SCRIP Round Table. |
Website |
Factsheets
| Title | Download |
| Company Factsheet | |
| CellJammer Factsheet | |
| PA401 Factsheet | |
| MCP-1 Factsheet | |